RSS   Newsletter   Contact   Advertise with us
Post Online Media

Immune appoints new chairman of the board

Ranch C. KimballImmune Pharmaceuticals Inc. announced it has appointed Ranch C. Kimball, a highly regarded executive in healthcare, government, and private equity, as chairman of its board of directors.

Mr. Kimball was the CEO of the Joslin Diabetes Center, a world-renowned institution affiliated with Harvard Medical School and one of only 11 NIH-designated Diabetes Research Centers in the U.S.

Article continues below

READ MORE Immune Design appoints Susan Kelley to board of directors

Mr. Kimball was the Secretary of Economic Development for the Commonwealth of Massachusetts, where he was responsible for managing 22 state agencies and 2,350 employees; one of his responsibilities was overseeing health insurance regulation.

While Secretary, he was a key leader in the state's landmark health care reform, "Romneycare."

Mr. Kimball was named the "Outstanding State Executive" nationally from BIO. He also co-chaired several health initiatives for the Massachusetts State Legislature and The Boston Foundation.

Most recently, Mr. Kimball served as President and CEO of CIC Partners, the arm of the Cambridge Innovation Center, the world's largest innovation center, responsible for the development of innovation centers outside the Boston-Cambridge region.

He has also served as the Chief Operating Officer of Babson College and served on their Executive Education and Curriculum Advisory Board.

In 2001, he co-founded the Washington D.C.-based Kissinger McLarty Capital Group, a private equity firm in partnership with former Secretary of State Henry Kissinger and former White House Chief of Staff and Fortune 500 CEO Thomas McLarty.

Mr. Kimball began his business career at the Boston Consulting Group, where he was a long-time partner with leadership in Boston, London, Tokyo, and Hong Kong.




What to read next



 LATEST MOVES FROM New York 


 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy